OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of…
Trial designed with a two-week run-in period to reduce the well-known placebo effect in trials involving pain componentTop-line data from trial anticipated in Q4, 2023 LONDON and NEW YORK,…